Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells

Neurochemical Research

Volumn 29, Issue 8, 2004, Pages 1529-1536

  Tanaka, Ken Ichi ^a   Asanuma, Masato ^b   Ogawa, Norio ^b  

^a SHUJITSU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antiapoptosis; BDNF; caspase; FK506; GDNF; glutathione; GPI1046; neurotrophic factor; oxidative stress; V10367

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; GLUTATHIONE; HYDROGEN PEROXIDE; IMMUNOPHILIN; LIGAND; MESSENGER RNA; NEUROTROPHIC FACTOR; PROTEIN P53; TACROLIMUS; UNCLASSIFIED DRUG; V 10367;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MOLECULAR MECHANICS; NEUROPROTECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

APOPTOSIS; BRAIN NEOPLASMS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; CELL SURVIVAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIOMA; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; IMMUNOPHILINS; LIGANDS; NERVE GROWTH FACTORS; PYRIDINES; PYRROLIDINES; TACROLIMUS;

EID: 3042739759     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000029565.92587.25     Document Type: Article

References (42)

1. Ogawa, N., Tanaka, K., Kondo, Y., Asanuma, M., Mizukawa, K., and Mori, A. 1993. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci. Lett. 152:173-176.
2. Sharkey, J. and Butcher, S. P. 1994. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature 371:336-339.
3. Gold, B. G. 1997. FK506 and the role of immunophilins in nerve regeneration. Mol. Neurobiol. 15:285-306.
4. Matsuura, K., Makino, H., and Ogawa, N. 1997. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 146:526-535.
5. Steiner, J. P., Connolly, M. A., Valentine, H. L., Hamilton, G. S., Hester, L., and Snyder, S. H. 1997. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nature Med. 3:421-428.
6. Snyder, S. H., Sabatini, D. M., Lai, M. M., Steiner, J. P., Hamilton, G. S., and Suzdak, P. D. 1998. Neural actions of immunophilin ligands. TiPS 19:21-26.
7. Gold, B. G., Zeleny-Pooley, M., Wang, M-S., Chaturvedi, P., and Aemistead, D. M. 1997. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:269-278.
8. Steiner, J. P., Hamilton, G. S., Rose, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J. H., Huang, W., Howorth, P., Soni, R., Fuller, M., Sauer, H., Nowotnik, A. C., and Suzdak, P. D. 1997. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA 94:2019-2024.
9. Costantini, L. C., Chaturvedi, P., Armistead, D. M., McCaffrey, P. G., Deacon, T. W., and Isacson, O. 1998. A novel immunophilin ligands: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease. Neurobiol. Dis. 5:97-108.
10. Sauer, H., Francis, J. M., Jiang, H., Hamilton, G. S., and Steiner, J. P. 1999. Systemic treatment with GPI 1046 improves spatial memory and reverses cholinergic neuron atrophy in the medial septal nucleus of aged mice. Brain Res. 842:109-118.
11. Gold, B. G. 2000. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Exp. Opin. Invest. Drugs 9:2331-2342.
12. Herdegen, T., Fischer, G., and Gold, B. G. 2000. Immunophilin ligands as a novel treatment for neurological disorders. TiPS 21:3-5.
13. 2-induced apoptotic cell death by increasing glutathione levels in Neuro 2A neuroblastoma cells. Acta Med. Okayama 54:275-280.
14. 2-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res. 889:236-239.
15. Tanaka, K., Fujita, N., Higashi, Y., and Ogawa, N. 2002. Effects of immunophilin ligands on hydrogen peroxide-induced apoptosis in C6 glioma cells. Synapse 43:219-222.
16. Tanaka, K., Yoshioka, M., Miyazaki, I., Fujita, N., and Ogawa, N. 2002. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. Neurosci. Lett. 321:45-48.
17. Halliwell, B. 1992. Reactive oxygen species in the central nervous system. J. Neurochem. 59:1609-1623.
18. Iwata-Ichikawa, E., Kondo, Y., Miyazaki, I., Asanuma, M., and Ogawa, N. 1999. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J. Neurochem. 72:2334-2344.
19. Higashi, Y., Asanuma, M., Miyazaki, I., Haque, M. E., Fujita, N., Tanaka, K., and Ogawa, N. 2002. The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis. J. Biol. Chem. 277:42224-42232.
20. Tietze, F. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:502-522.
21. Tanaka, K., Miyazaki, I., Fujita, N., Haque, M. E., Asanuma, M., and Ogawa, N. 2001. Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist. Neurochem. Res. 26:31-36.
22. Bredesen, D. E. 1995. Neural apoptosis. Ann. Neurol. 38:839-851.
23. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770-776.
24. Kroemer, G. and Reed, J. C. 2000. Mitochondrial control of cell death. Nat. Med. 6:513-519.
25. Adams, J. M. and Cory, S. 2001. Life-or death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:61-66.
26. Friberg, H. and Wieloch, T. 2002. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84:241-250.
27. Uberti, D., Yavin, E., Gil, S., Ayasola, K. R., Goldfinger, N., and Rotter, V. 1999. Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. Mol. Brain Res. 65:167-175.
28. Chandra, J., Samali, A., and Orrenius, S. 2000. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:323-333.
29. Peter, M. E. and Krammer, P. H. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10:545-551.
30. Zou, H., Li, Y., Liu, X., and Wang, X. 1999. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549-11556.
31. Saleh, A., Srinivasula, S. M., Acharya, S., Fishel, R., and Alnemri, E. S. 1999. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 274:17941-17945.
32. Matsura, T., Kai, M., Fujii, Y., Ito, H., and Yamada, K. 1999. Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radic. Res. 30:73-83.
33. Cooper, A. J. L. and Kristal, B. S. 1997. Multiple roles of glutathione in the central nervous system. Biol. Chem. 378:793-802.
34. Hall, A. 1999. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29:238-245.
35. Wang, X. F. and Cynader, M. S. 2000. Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 74:1434-1442.
36. Lin, L. F. H., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
37. Abe, K. 2000. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J. Cereb. Blood Flow Metab. 20:1393-1408.
38. Yuan, J. and Yanker, B. A. 2000. Apoptosis in the nervous system. Nature 407:802-809.
39. Kirschner, P. B., Jenkins, B. G., Schulz, J. B., Finkelstein, S. P., Matthews, R. T., Rosen, B. R., and Beal, M. F. 1996. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Res. 713:78-185.
40. Yamagata, T., Satoh, T., Ishikawa, Y., Nakatani, A., Yamada, M., Ikeuchi, T., and Hatanaka, H. 1999. Brain-derived neurotrophic factor prevents superoxide anion-induced death of PC12h cells stably expressing TrkB receptor via modulation of reactive oxygen species. Neurosci. Res. 35:9-17.
41. Toth, G., Yang, H., Anguelov, R. A., Vettraino, J., Wang, Y., and Acsadi, G. 2002. Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway. J. Neurosci. Res. 69:622-632.
42. Guo, X., Dillman, J. F., Dawson, V. L., and Dawson, T. M. 2001. Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann. Neurol. 50:6-16.